A "Smart" ¹²⁸Xe NMR Biosensor for pH-Dependent Cell Labeling.
暂无分享,去创建一个
I. Dmochowski | Brittany A Riggle | Yanfei Wang | Yanfei Wang | Ivan J Dmochowski | Brittany A. Riggle
[1] Robert E Lenkinski,et al. PARACEST agents: modulating MRI contrast via water proton exchange. , 2003, Accounts of chemical research.
[2] À. Muñoz-Castro. Behavior of [2.2]paracyclophane in magnetic fields: A survey of the magnetic response properties from chemical shift tensor maps , 2011 .
[3] Andrew Tsourkas,et al. pH-titratable superparamagnetic iron oxide for improved nanoparticle accumulation in acidic tumor microenvironments. , 2011, ACS nano.
[4] R.J. Gillies,et al. pH imaging , 2004, IEEE Engineering in Medicine and Biology Magazine.
[5] R. Murphy,et al. Design of a pH-sensitive pore-forming peptide with improved performance. , 2008, The journal of peptide research : official journal of the American Peptide Society.
[6] F. Szoka,et al. pH-dependent bilayer destabilization by an amphipathic peptide. , 1987, Biochemistry.
[7] Eva K. Lee,et al. Systems Biology of Seasonal Influenza Vaccination in Humans , 2011, Nature Immunology.
[8] C. Freund,et al. Multichannel MRI labeling of mammalian cells by switchable nanocarriers for hyperpolarized xenon. , 2014, Nano letters.
[9] A. Pines,et al. HyperCEST detection of a 129Xe‐based contrast agent composed of cryptophane‐A molecular cages on a bacteriophage scaffold , 2013, Magnetic resonance in medicine.
[10] H. Benyamini,et al. Formation and characterization of stable human serum albumin-tris-malonic acid [C60]fullerene complex. , 2005, Bioconjugate chemistry.
[11] L. Dubois,et al. Water soluble cryptophanes showing unprecedented affinity for xenon: candidates as NMR-based biosensors. , 2006, Journal of the American Chemical Society.
[12] I. Dmochowski,et al. Cryptophane-Folate Biosensor for 129Xe NMR , 2014, Bioconjugate chemistry.
[13] P. Wahl,et al. pH dependence of the fluorescence decay of tryptophan. , 1970, Biochemistry.
[14] Vipul R Sheth,et al. Measuring in vivo tumor pHe with CEST‐FISP MRI , 2012, Magnetic resonance in medicine.
[15] F. Gallagher,et al. Imaging pH with hyperpolarized 13C , 2011, NMR in biomedicine.
[16] T. Delair,et al. A cryptophane biosensor for the detection of specific nucleotide targets through xenon NMR spectroscopy. , 2007, Chemphyschem : a European journal of chemical physics and physical chemistry.
[17] U. Resch‐Genger,et al. Biomembrane interactions of functionalized cryptophane-A: combined fluorescence and 129Xe NMR studies of a bimodal contrast agent. , 2013, Chemistry.
[18] J. Bulte,et al. New “multicolor” polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI , 2008, Magnetic resonance in medicine.
[19] Alan P Koretsky,et al. MRI detection of single particles for cellular imaging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Pines,et al. Xenon-based molecular sensors in lipid suspensions. , 2010, Journal of magnetic resonance.
[21] Comparison of divalent transition metal ion paraCEST MRI contrast agents , 2014, JBIC Journal of Biological Inorganic Chemistry.
[22] You Han Bae,et al. Recent progress in tumor pH targeting nanotechnology. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[23] Gregory S Karczmar,et al. MRI of the tumor microenvironment , 2002, Journal of magnetic resonance imaging : JMRI.
[24] D. Engelman,et al. pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation , 2010, Proceedings of the National Academy of Sciences.
[25] J. Dutasta,et al. A sensitive zinc-activated 129Xe MRI probe. , 2012, Angewandte Chemie.
[26] T. Troxler,et al. Substituent effects on xenon binding affinity and solution behavior of water-soluble cryptophanes. , 2009, Journal of the American Chemical Society.
[27] J. Dutasta,et al. A cryptophane core optimized for xenon encapsulation. , 2007, Journal of the American Chemical Society.
[28] D. Christianson,et al. Cryptophane xenon-129 nuclear magnetic resonance biosensors targeting human carbonic anhydrase. , 2009, Journal of the American Chemical Society.
[29] Hakho Lee,et al. Magnetic nanoparticles for biomedical NMR-based diagnostics , 2010, Beilstein journal of nanotechnology.
[30] Y. Ko,et al. Water soluble cucurbit[6]uril derivative as a potential Xe carrier for 129Xe NMR-based biosensors. , 2008, Chemical communications.
[31] A. Pines,et al. Functionalized xenon as a biosensor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[32] I. Dmochowski,et al. Cell-compatible, integrin-targeted cryptophane-129Xe NMR biosensors. , 2011, Chemical science.
[33] J. Dutasta,et al. A water-soluble Xe@cryptophane-111 complex exhibits very high thermodynamic stability and a peculiar (129)Xe NMR chemical shift. , 2010, Journal of the American Chemical Society.
[34] A. Tsourkas,et al. Gd-labeled glycol chitosan as a pH-responsive magnetic resonance imaging agent for detecting acidic tumor microenvironments. , 2013, Journal of medicinal chemistry.
[35] J. Dutasta,et al. Cell uptake of a biosensor detected by hyperpolarized 129Xe NMR: the transferrin case. , 2011, Bioorganic & medicinal chemistry.
[36] Christian Hilty,et al. Molecular Imaging Using a Targeted Magnetic Resonance Hyperpolarized Biosensor , 2006, Science.
[37] T. Meade,et al. Cell Labeling via Membrane-Anchored Lipophilic MR Contrast Agents , 2014, Bioconjugate chemistry.
[38] I. Dmochowski,et al. Thermodynamics of Xenon Binding to Cryptophane in Water and Human Plasma [J. Am. Chem. Soc. 2007, 129, 9262−9263]. , 2007 .
[39] Yu Sui,et al. Spectroscopic study on the interaction of pristine C60 and serum albumins in solution , 2012, Nanoscale Research Letters.
[40] L. Laureano-Pérez,et al. Measurement of radon and xenon binding to a cryptophane molecular host , 2011, Proceedings of the National Academy of Sciences.
[41] R. Gillies,et al. Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T1 and T2 contrast agents , 2011, NMR in biomedicine.
[42] I. Dmochowski,et al. Peptide-mediated cellular uptake of cryptophane. , 2008, Bioconjugate chemistry.
[43] A. Kondo,et al. A display of pH-sensitive fusogenic GALA peptide facilitates endosomal escape from a Bio-nanocapsule via an endocytic uptake pathway , 2014, Journal of Nanobiotechnology.
[44] Luke G Green,et al. A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. , 2002, Angewandte Chemie.
[45] C. Freund,et al. Cell tracking with caged xenon: using cryptophanes as MRI reporters upon cellular internalization. , 2014, Angewandte Chemie.
[46] F. Szoka,et al. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. , 2004, Advanced drug delivery reviews.
[47] Patrick Berthault,et al. Effect of pH and counterions on the encapsulation properties of xenon in water-soluble cryptophanes. , 2010, Chemistry.
[48] V. Bajaj,et al. A xenon-based molecular sensor assembled on an MS2 viral capsid scaffold. , 2010, Journal of the American Chemical Society.
[49] D. Engelman,et al. pHLIP-mediated translocation of membrane-impermeable molecules into cells. , 2009, Chemistry & biology.
[50] H. Rose,et al. Live-cell MRI with xenon hyper-CEST biosensors targeted to metabolically labeled cell-surface glycans. , 2015, Angewandte Chemie.
[51] M. Goulian,et al. Bacterial spore detection and analysis using hyperpolarized 129Xe chemical exchange saturation transfer (Hyper-CEST) NMR. , 2014, Chemical science.
[52] F. Szoka,et al. Orientation of the pore-forming peptide GALA in POPC vesicles determined by a BODIPY-avidin/biotin binding assay. , 1999, Biophysical journal.
[53] Robert J Gillies,et al. High resolution pHe imaging of rat glioma using pH‐dependent relaxivity , 2006, Magnetic resonance in medicine.
[54] I. Dmochowski,et al. Designing 129Xe NMR biosensors for matrix metalloproteinase detection. , 2006, Journal of the American Chemical Society.
[55] Morten Meldal,et al. Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. , 2002, The Journal of organic chemistry.
[56] Suresh Neethirajan,et al. A novel microfluidic wound model for testing antimicrobial agents against Staphylococcus pseudintermedius biofilms , 2014, Journal of Nanobiotechnology.
[57] Yana K Reshetnyak,et al. A novel technology for the imaging of acidic prostate tumors by positron emission tomography. , 2009, Cancer research.
[58] K. Kinzler,et al. A diaCEST MRI approach for monitoring liposomal accumulation in tumors. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[59] D. Engelman,et al. pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents , 2010, Molecular membrane biology.
[60] S. Futaki,et al. An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives , 2008, Analytical and bioanalytical chemistry.
[61] Masaya Takahashi,et al. A novel class of polymeric pH-responsive MRI CEST agents. , 2013, Chemical communications.
[62] O. Togao,et al. Multi-chromatic pH-activatable 19F-MRI nanoprobes with binary ON/OFF pH transitions and chemical-shift barcodes. , 2013, Angewandte Chemie.
[63] T. Andresen,et al. A GALA lipopeptide mediates pH- and membrane charge dependent fusion with stable giant unilamellar vesicles , 2012 .
[64] R Weissleder,et al. Magnetically labeled cells can be detected by MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[65] Peter Caravan,et al. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. , 2006, Chemical Society reviews.
[66] Xenon NMR Spectroscopy , 1994 .
[67] I. Dmochowski,et al. Synthesis of enantiopure, trisubstituted cryptophane-A derivatives. , 2012, Organic letters.
[68] A. Collet,et al. Synthesis of a (D3)-bis(cyclotriveratrylenyl) macrocage by stereospecific replication of a (C3)-subunit , 1981 .
[69] Robert J. Gillies,et al. Tumor pH and Its Measurement , 2010, The Journal of Nuclear Medicine.
[70] Pernille R. Jensen,et al. Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate , 2008, Nature.
[71] A. Hatefi,et al. A recombinant biopolymeric platform for reliable evaluation of the activity of pH-responsive amphiphile fusogenic peptides. , 2013, Biomacromolecules.
[72] B. Rutt,et al. Application of the static dephasing regime theory to superparamagnetic iron‐oxide loaded cells , 2002, Magnetic resonance in medicine.
[73] P. Z. Sun,et al. A General MRI-CEST Ratiometric Approach for pH Imaging: Demonstration of in Vivo pH Mapping with Iobitridol , 2014, Journal of the American Chemical Society.
[74] P. Tang,et al. Amphiphilic sites for general anesthetic action? Evidence from 129Xe-[1H] intermolecular nuclear Overhauser effects. , 1997, Biochimica et biophysica acta.
[75] I. Dmochowski,et al. Utilizing a water-soluble cryptophane with fast xenon exchange rates for picomolar sensitivity NMR measurements. , 2012, Analytical chemistry.
[76] Junfa Yin,et al. Interaction of Human Serum Album and C60 Aggregates in Solution , 2011, International journal of molecular sciences.
[77] R. Lenkinski,et al. CEST and PARACEST MR contrast agents , 2010, Acta radiologica.
[78] Seok-Yong Lee,et al. Detection and characterization of xenon-binding sites in proteins by 129Xe NMR spectroscopy. , 2002, Journal of molecular biology.